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Non-viral gene delivery vectors are attractive due to their potential safety and ease of
manufacture, but low transfection potency and poor formulation stability have limited their
application. Among the numerous materials that have been studied for gene delivery, poly(β-
amino ester)s (PBAEs) represent one promising class of degradable delivery materials. Here,
we develop PBAE terpolymers incorporating hydrophobic alkyl side chains that exhibit
significantly enhanced transfection potency and resistance to aggregation. Top-performing
PBAE terpolymers demonstrated significantly higher transfection potencies in HeLa cells
than the commercial reagent, Lipofectamine 2000. Inclusion of alkyl side chains promoted
the stability of polymer-DNA complexes under physiological conditions. Furthermore, at
high DNA concentrations, PBAE terpolymers with alkyl side chains, but not PBAEs lacking
them, could support functionalization with PEG-lipid conjugates to yield particles that
maintained their size and transfection activity after incubation at high ionic strength for
several hours. The marked improvements in nanoparticle transfection potency and stability
offered by these degradable PBAE terpolymers may facilitate the in vivo translation of these
materials.
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Gene therapy is a promising treatment strategy for a variety of inherited and acquired
diseases, but safe and efficient delivery remains a challenge. Though gene therapy mediated
by viral vectors has recently made great clinical progress, limitations associated with their
use persist, such as the possibility of adverse immune reactions, the difficulty of repeat
dosing, and small DNA loading capacities.[1, 2] Non-viral vectors, meanwhile, continue to
suffer from generally low DNA delivery efficiency.[3] Nonetheless, the diversity of synthetic
materials offers potential for the identification and incorporation of functional motifs that
confer not only efficient gene transfection, but also formulation stability and
biocompatibility.[4]
Poly(β-amino ester)s (PBAEs) are a class of cationic gene delivery polymers that have been
studied pre-clinically for applications including local cancer therapy and the genetic
modification of stem cells for treatment of ischemia[5, 6]. Synthesis is relatively simple and
versatile, and is based on the Michael-type conjugate addition of a primary or secondary
amine to a diacrylate. Using this approach, combinatorial library synthesis and high-
throughput screening methods have been developed to identify polymers that deliver DNA
with high efficiency and low cytotoxicity[7-9]. Through these experiments, structural
features associated with highly active gene delivery polymers have emerged, such as the
presence of hydroxyl groups in the side chains and the conjugation of certain primary
amines to the chain ends[10-13]. In addition to high transfection efficiency, the degradability
of the polyester backbone offers the possibility of reduced toxicity and rapid clearance, a
feature that distinguishes PBAEs from polyethylenimine (PEI), the most widely used gene
delivery polymer[14].
Cationic polymers can form polymer-DNA polyplexes that may aggregate under
physiological conditions[15, 16]. This potential aggregation in the blood represents a serious
barrier to the systemic delivery of nucleic acids, since large aggregates can in some cases
lead to embolism or otherwise may be quickly cleared by the reticuloendothelial
system[16, 17]. Colloidal stability is a complex phenomenon influenced by many factors
including concentration, surface charge, pH, ionic strength, and the presence of serum
proteins, but a common approach to improve formulation stability is to introduce a polymer
shield comprising polyethyleneglycol (PEG), poloxamers, or other non-fouling polymers[18].
Although attachment of PEG can be covalent or non-covalent, the latter may be preferable to
avoid potential issues resulting from direct PEGylation of gene delivery polymers, such as
impaired DNA condensation and decreased uptake[19, 20]. For nanoparticles with sufficiently
hydrophobic surfaces, one simple non-covalent approach entails coating the particles with
PEGylated phospholipid conjugates[21]. Therefore, we hypothesized that the inclusion of
long, linear alkanes in PBAE side chains might facilitate non-covalent, hydrophobic
interaction with PEG-lipid conjugates, resulting in stable particle formulations upon
nanoprecipitation with DNA at high concentration. Because the modification of cationic
polymers with hydrophobic groups has been reported to increase the physical encapsulation
of nucleic acids, promote cellular adsorption, and reduce the positive surface charge
associated with cytotoxicity and aggregation, we further hypothesized that hydrophobic
PBAE terpolymers might deliver DNA more efficiently than PBAEs lacking alkyl side
chains and might condense DNA into polyplexes with greater aggregation resistance[22-24].
In this study, we synthesized random PBAE terpolymers by step-growth polymerization of
three starting monomers: a diacrylate, a hydrophobic alkylamine, and a comparatively
hydrophilic amine. Previous work has shown the importance of terminal amine
groups[11, 12]. Therefore, we used a two-step reaction scheme involving co-polymerization
of the amine monomers with excess diacrylate to yield acrylate-terminated base polymer,
followed by reaction with excess diamine to produce amine end-modified PBAE terpolymer
(Fig. 1a). Because it is not easily predicted which PBAEs would benefit from the inclusion
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of alkyl side chains, we used combinatorial library synthesis and screening as a tool to
accelerate their development. Our initial library (Fig. 1b) consisted of 80 amine-end
modified PBAE terpolymers synthesized using 8 diacrylates, 10 hydrophilic amines, one
hydrophobic amine (dodecylamine), and one end-capping diamine (“122”). Based on pilot
studies, we chose a monomer molar feed ratio of 1.2:0.7:0.3 diacrylate:hydrophilic
amine:hydrophobic amine for the polymerization, and the reactions were carried out in
DMSO. Under these conditions, eight of the 80 polymers precipitated out of reaction, while
the remaining library members were soluble.
Using these 72 polymers, we formed complexes with GFP-encoding plasmid DNA and
incubated them with cultured HeLa cells in serum-containing growth medium for 4 h. As a
screen for transfection efficiency, we performed fluorescence-activated cell sorting (FACS)
48 h later to quantify the proportion of cells expressing GFP. As shown in the heat map (Fig.
2a), the top five PBAE terpolymers transfected over 70% of HeLa cells, and four of these
five, D90-C12-122, D60-C12-122, D21-C12-122, and D24-C12-122, shared a common
diacrylate structure based on bisphenol A ethoxylate (“D”). The top two polymers from this
screen outperformed one of the best previously identified PBAEs lacking alkyl side chains,
C32-122, and rivaled the commercially available lipid reagent Lipofectamine 2000 in
transfection efficiency (Fig. 2b).
To investigate the structural space surrounding these polymers, we synthesized a second
library of hydrophobic PBAE terpolymers focused on bisphenol diacrylate monomers (Fig.
1c). When we screened this set of polymers for transfection efficiency at half the DNA dose
used in the first library, five polymers emerged in addition to D60-C12-122 and D90-
C12-122 that transfected HeLa cells with greater than 85% efficiency (Fig. 2c). After
resynthesizing these polymers on a larger scale, and transfecting cells at reduced DNA
doses, we observed that these five polymers, based on DD24, DD90, DD60, DF90, and
DF60, exhibited transfection potencies in HeLa cells superior to Lipofectamine 2000 (Fig.
2d, Fig. S1). These polymers were generally short, ranging in weight-average molecular
weight (Mw) from 2.40 to 2.94 kDa with polydispersity indices (PDI) from 1.7 to 2.3 (Table
S1). DD24-C12-122, in particular, appeared to be the most potent terpolymer to emerge
from these screens, yielding ~80% transfection efficiency at the 50 ng dose without
producing significant toxicity (Fig. 2e). This polymer was purified by preparative gel
permeation chromatography (GPC) using an HPLC system (Fig. S2). The resulting polymer
(Mw = 4.37 kDa, PDI = 1.43) was characterized by 1H-NMR spectroscopy, which confirmed
the incorporation of the hydrophobic amine as well as the end-capping amine (Fig. S3).
When we used dynamic light scattering (DLS) measurements to compare the stabilities of
D60-C12-122, D90-C12-122, and C32-122 polyplexes formed at low DNA concentration,
we observed that all three polymers formed stable, sub-100 nm complexes with plasmid
DNA under conditions of reduced pH and low ionic strength (Fig. 3a). However, when the
polyplexes were diluted in phosphate-buffered saline (PBS) at physiological pH and ionic
strength, only the complexes formed from the PBAE terpolymers remained stable, with
effective diameters below 100 nm (Fig. 3b).
To examine the effect of alkyl side chain content on PBAE terpolymer transfection
efficiency and complex stability in greater depth, we synthesized D60-C12-122 using a
range of molar feed ratios for which the dodecylamine (C12) feed varied from 0 to 50 mol%
of the total amine feed, while the diacrylate:amine ratio was kept constant at 1.2:1.0. An
increase in the alkylamine feed ratio up to 30 mol% C12 generally corresponded to an
increase in transfection potency in HeLa cells, with a rough plateau in efficiency between 30
and 50 mol% C12 (Fig. 3c). Interestingly, the alkylamine feed ratio also appeared to
correlate positively with polyplex stability in PBS (Fig. 3d). One hour after dilution in PBS,
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polyplexes formed from D60-122 polymer lacking alkyl side chains grew 50% in diameter,
in contrast to <10% growth for those formed from D60-122 terpolymers synthesized with
C12 feed ratios at or above 20 mol%.
To determine how the alkyl side chain length affects the gene delivery efficiency of PBAE
terpolymers, we synthesized C32-122 and DD24-122 using alkylamines ranging from 8 to
16 carbons in length. We also varied the alkylamine molar feed from 0 to 40 mol% of the
total amine feed, with the diacrylate:amine molar ratio fixed at 1.2:1.0. We observed a
positive association between the alkyl side chain length of C32-122 terpolymers and
transfection efficiency of HeLa cells (Fig. 3e). As was true for D60-122, there was also a
positive correlation between alkylamine feed ratio and transfection activity of the C32-122
terpolymers. At this DNA dose, though, varying the alkyl side chain length and content of
DD24-122 terpolymers did not yield much variation in observed transfection efficiencies of
HeLa cells (Fig. 3f). Nonetheless, for both C32-122 and DD24-122, the best-performing
hydrophobic terpolymers produced a marked enhancement in transfection activity relative to
the polymers synthesized without alkylamine (C32-122: 0.22% vs. 78.1%; DD24-122: 4.2%
vs. 87.5%).
Because polymer terminal group modification has been previously shown to affect
transfection efficiency[11, 12], we also synthesized C32-C12 and DD24-C12 polymers with
end-capping diamines other than 122 (Fig. S4a). For the C32 terpolymers, amine end-
modification dramatically influenced transfection efficiency, but for the DD24 terpolymers,
there was less variation at this dose (Fig. S4b). We expect that at lower DNA doses, we
would observe greater variation in transfection activity as a result of changes to the
alkylamine feed ratio and terminal groups of DD24 terpolymers.
Due to their low molecular weights and high polydispersities, the polymers resulting from
the step-growth polymerization of the three starting monomers likely represent a mixture of
three species: copolymers of the diacrylate and the hydrophilic amine, copolymers of the
diacrylate and the hydrophobic amine, and finally terpolymers incorporating all three
monomers. To elucidate which species is responsible for the observed enhancements in
transfection potency and nanoparticle stability, and whether there might be a synergistic
interaction between the relatively hydrophilic and hydrophobic copolymer species, we
prepared four PBAE variants containing the DD diacrylate: one synthesized with only the
hydrophilic 24 amine (DD24-122, DD:24 = 1.2:1.0 mol/mol, Mw = 2.48 kDa); another
synthesized with only the hydrophobic C12 amine (DDC12-122, DD:C12 = 1.2:1.0, Mw =
5.38 kDa); a third synthesized with 70 mol% of the hydrophilic amine and 30% of the
hydrophobic amine (DD24-C12-122, DD:24:C12 = 1.2:0.7:0.3, Mw = 3.03 kDa); and a
fourth comprising a 70%:30% v/v mixture of DD24-122 to DDC12-122 (Mw = 3.44 kDa).
To avoid polymer crosslinking that was observed at high molar ratios of the C12 amine,
these end-capping reactions were performed at room temperature rather than at 40°C. When
we examined polyplex stabilities in PBS, only the relatively hydrophilic DD24-122 was
unstable, whereas DDC12-122, DD24-C12-122, and the polymer mixture all resisted
aggregation (Fig. S5a). When we compared their transfection efficiencies, the polymer
synthesized using all three monomers (DD24-C12-122) was significantly more potent than
the mixture of the DD24-122 and DDC12-122 polymers, as well as the hydrophobic
DDC12-122 polymer alone (Fig. S5b). These data suggest that although a synergistic effect
between the hydrophilic and hydrophobic polymers may contribute to polyplex stability, the
presence of terpolymer species incorporating both the hydrophilic and hydrophobic amines
is most likely responsible for the enhanced potency of the alkane-containing PBAEs.
Finally, to test our hypothesis that the incorporation of hydrophobic side chains in PBAEs
can facilitate their interaction with PEG-lipid conjugates, we used a nanoprecipitation
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approach to formulate particles comprised of polymer and DNA in the presence or absence
of PEG-lipid. Working with C32-122 and D60-122-based polymers, we dissolved either the
copolymers lacking alkyl side chains (C:32 = 1.2:1.0 mol/mol; D:60 = 1.2:1.0) or the
terpolymer variants (C:32:C12 = 1.2:0.7:0.3; D:60:C12 = 1.2:0.7:0.3) in acetonitrile with or
without PEG-lipid and mixed them with DNA at high concentration in sodium acetate buffer
at pH 5.2. To remove the organic solvent, we then dialyzed the formulations against PBS for
3 h. Comparing particle sizes before and after dialysis, we found that only the formulations
employing both the terpolymers and the PEG-lipid conjugate gave rise to well-defined and
stable nanoparticles (Fig. 4a). At this high DNA concentration, D60-122, for instance,
produced large particles ~1 μm in size whether or not PEG-lipid was present. In contrast,
when PEG-lipid was present, the terpolymer version, D60-C12-122, produced particles that
remained stable after dialysis at ~250 nm in size; in the absence of PEG-lipid, the particles
grew to >700 nm in diameter after dialysis, a size which seemed poorly defined given the
large variation between replicate measurements. When we then transfected HeLa cells using
identical volumes of formulation per well, corresponding to approximately 75 ng and 150 ng
of DNA, we found that only the terpolymer formulations including PEG-lipid yielded
significant transfection (Fig. 4b, Fig. S6). Further support for non-covalent interaction of the
PEG-lipid conjugate was provided by ζ-potential measurements, which showed a reduction
in ζ-potential upon inclusion of PEG-lipid for particles formed from hydrophobic C32-122
terpolymers, but not for particles formed from regular C32-122 (Table S2). Taken together,
these data suggest that at high DNA concentration, PBAE terpolymers incorporating alkyl
side chains, but not polymers lacking them, are capable of interacting with PEG-lipid
conjugates and DNA to form stable nanoparticles, and that these particles retain the ability
to mediate gene delivery.
Due to the commercial availability of functionalized PEG-lipid conjugates, the capacity of
the hydrophobic PBAE terpolymers to support formulation with PEG-lipid represents a
straightforward non-covalent method for attaching targeting ligands such as peptides to the
polymer/DNA nanoparticles. Although the particles produced using a combination of PBAE
terpolymers and PEG-lipid were rather large here, with effective diameters of ~250-350 nm,
there is likely significant potential for optimization of particle size through variation of the
PBAE alkyl side chain length and content, the ratio of PBAE:DNA:PEG-lipid, the lengths of
the lipid tails and PEG polymer in the PEG-lipid conjugate, and the use of additional
excipients such as cholesterol or poloxamers. Furthermore, increasing the mixing rate with
the aid of a microfluidic mixing device should enable the formulation of smaller
nanoparticles[25].
In summary, we employed parallel synthesis and screening as a tool to accelerate the
development of degradable alkane-containing PBAE terpolymers for gene delivery, guided
by our hypothesis that they might provide superior transfection potency and particle stability
over polymers lacking hydrophobic side chains. The top-performing PBAE terpolymers
exhibited transfection potencies in HeLa cells significantly higher than that of
Lipofectamine 2000. Transfection efficiency was generally positively correlated with
increasing hydrophobicity, as defined by either increasing the feed ratio of alkylamine
monomer or increasing its chain length. Increasing the hydrophobic content of the polymers
also appeared to be associated with greater polyplex stability at low DNA concentration. At
high DNA concentrations under conditions of physiological pH and ionic strength, these
hydrophobic PBAE terpolymers were better able to facilitate interaction with PEG-lipid and
DNA to yield stable, well-defined nanoparticles capable of transfecting cultured cells in
vitro. This simple yet powerful approach to improving the transfection potency and
formulation stability of degradable cationic polymers may facilitate the development of
multifunctional, nanoparticulate gene delivery systems suitable for in vivo application.
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Experimental
Materials
Diacrylate and amine monomers, as well as end-capping reagents, were purchased from
Sigma-Aldrich (St. Louis, MO, USA), Alfa Aesar (Ward Hill, MA, USA), TCI America
(Portland, OR, USA), and Monomer-Polymer & Dajac Labs (Trevose, PA, USA). (PEO)4-
bis-amine (“122”) was acquired from Molecular Biosciences (Boulder, CO, USA). All
reagents were used without further purification. Plasmid DNA encoding green fluorescent
protein (gWiz-GFP) was purchased from Aldevron (Fargo, ND, USA). PEG-lipid conjugate
(1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-5000],
or 18:0 PEG5000 PE) was obtained from Avanti Polar Lipids (Alabaster, AL, USA). Slide-
A-Lyzer MINI dialysis devices (20 kDa MWCO, 0.1ml) were purchased from Pierce
Biotechnology (Rockford, IL, USA). HeLa cells (ATCC, Manassas, VA, USA) were
cultured in DMEM (Invitrogen, Carlsbad, CA, USA) supplemented with 10% fetal bovine
serum (Invitrogen).
Polymer synthesis
The monomers were dissolved in DMSO (Sigma-Aldrich) to a concentration of 200 mg
ml−1. Alkylamines generally required heating to 60°C to enable complete dissolution.
Library scale reactions were performed in glass shell vials (1 mL) with polyethylene snap
caps (Waters, Milford, MA, USA) in a 96-well reaction block (Symyx, Santa Clara, CA,
USA). To each vial equipped with stir bar, diacrylate monomer, hydrophobic amine
monomer, and hydrophilic amine monomer were added such that their molar ratio was
1.2:0.3:0.7 and the total mass of monomers was 100 mg. After heating and stirring at 90°C
for 48 h, the reactions were allowed to cool to RT, and to each vial, end-capping amine (0.2
mmol in 0.5 mL DMSO) was added. The reactions were stirred at 40°C for 24 h, divided
into aliquots, and then stored frozen at −20°C. Top-performing polymers were resynthesized
by scaling up the reactions tenfold.
Analytical Gel Permeation Chromatography (GPC)
GPC was performed using a Waters system equipped with a 2400 differential refractometer,
515 pump, and 717-plus autosampler. The flow rate was 1 ml min−1 and the mobile phase
was tetrahydrofuran (THF). The Styragel columns (Waters) and detector were thermostated
at 35°C. Linear polystyrene standards were used for calibration.
Preparative GPC/HPLC
DD24-C12-122 was subjected to GPC using a Phenogel 5 μm MXL gel filtration column
(300 mm × 7.8 mm, Phenomenex, P/No. 00H-3087-KO) with THF as the mobile phase at a
flow rate of 1 ml min−1. The separation was performed on a 1200 Series Agilent HPLC
system equipped with a UV diode array detector and a 1260 Infinity analytical scale fraction
collector. The column compartment was kept at 40°C during fractionation. Based on the
absorption of the polymer at 260 nm (Fig. S2), polymer was collected between 5.2 and 7.7
min. The fractionated polymer was transferred to a tared vial and dried until further analysis.
NMR
The HPLC-purified DD24-C12-122 polymer, along with the monomers and end-capping
reagent, was characterized on a Varian mercury spectrometer by 1H-NMR spectroscopy
(500 MHz, DMSO-d6).
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Transfection experiments
One day before transfection, 12,500 HeLa cells (100 μl) were seeded into each well of a 96-
well polystyrene tissue culture plate. In a typical example, for a 150 ng/well DNA dose,
gWiz-GFP plasmid DNA (5 mg ml−1) was diluted to 15 μg ml−1 in 25 mM sodium acetate
(NaOAc) buffer at pH 5.2. Polymers (100 mg ml−1) were thawed immediately prior to
transfection and diluted in NaOAc buffer to a concentration of 300 μg ml−1 (20:1 w/w
polymer:DNA). To form DNA-polymer nanoparticles, polymer solution (25 μl) was added
to DNA (25 μl) in a half-area 96-well plate, mixed by repeated pipetting using a
multichannel pipette, and allowed to incubate for 10 min at room temperature. Polymer-
DNA complexes (30 μl) were then gently mixed with fresh medium (195 μl) pre-warmed to
37°C. Conditioned medium was removed using a 12-channel aspirating wand and replaced
with the complexes diluted in medium (150 μl). Following a 4-h incubation, complexes were
removed with the aid of a multi-channel aspiration wand and replaced with fresh medium
(100 μl). Lipofectamine 2000 (Invitrogen) was used according to the protocol provided by
the vendor.
Fluorescence-activated cell sorting (FACS)
GFP expression was assessed 48 h after transfection. After aspirating conditioned medium,
cells were washed with PBS and detached with 0.25% trypsin-EDTA (25 μl, Invitrogen).
FACS running buffer (50 μl), consisting of 98% PBS and 2% FBS, was added to each well.
Cells were mixed thoroughly and then transferred to a 96-well round-bottom plate. GFP
expression was measured using FACS on a BD LSR II (Becton Dickinson, San Jose, CA,
USA). To determine the viabilities of treated cells relative to non-treated control cells,
propidium iodide stain (Invitrogen) was added to the FACS buffer (1:200 v/v). The relative
viability was calculated as the ratio of live treated cells per well to the mean number of live
non-treated cells per well. 2D gating was used to separate increased auto-fluorescence
signals from increased GFP signals to more accurately count positively expressing cells.
Gating and analysis were performed using FlowJo v8.8 software (TreeStar, Ashland, OR,
USA).
Particle formulation with PEG-lipid at high DNA concentration
Polymer in DMSO (100 mg ml−1) and 18:0 PEG5000 PE in ethanol (10 mg ml−1) were co-
dissolved in acetonitrile to yield final concentrations of 8 mg ml−1 and 10 mol%,
respectively. gWiz-GFP plasmid DNA (5 mg ml−1) was diluted to 0.4 mg ml−1 in 25 mM
NaOAc buffer. The polymer and PEG-lipid in acetonitrile (25 μl) was then added to DNA
(25 μl) and mixed by repeated pipetting. After incubation for 10 min, the formulations were
diluted in PBS (50 μl) and dialyzed against PBS (3 l) for 3 h at RT.
Dynamic light scattering (DLS) measurements
Particle sizes and ζ potentials were measured using a ZetaPALS DLS detector (Brookhaven
Instruments Corp., Holtsville, NY, USA, 15-mW laser, incident beam 676 nm). Correlation
functions were collected at a scattering angle of 90°, and particle sizes were obtained from
the MAS option of BIC’s particle sizing software (v. 2.30) using the viscosity and refractive
index of water at 25°C. Particle sizes are expressed as effective diameters (z-average or
hydrodynamic diameters) calculated using the Stokes-Einstein relationship from the
diffusion coefficient obtained by cumulant analysis.Average electrophoretic mobilities were
measured at 25°C using BIC PALS ζ-potential analysis software, and ζ-potentials were
calculated using the Smoluchowski model for aqueous suspensions. For polyplex sizing,
particles were prepared in NaOAc buffer as for DNA transfection, except volumes were
scaled up by a factor of five. Once formed in NaOAc buffer, complexes were diluted
fourfold in either additional NaOAc buffer or PBS and then sized at the indicated times. For
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DLS measurements of particles prepared by nanoprecipitation, particles (either freshly
prepared or dialyzed) were diluted 100-fold in NaOAc buffer or PBS as indicated.
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Figure 1.
a) Two-step synthesis of hydrophobic, amine end-modified poly(β-amino ester) (PBAE)
terpolymers. b) Structures of diacrylates (A-LL), hydrophilic amines (20-94), hydrophobic
amine (C12), and end-capping diamine (122) used for the synthesis of the initial screening
library. c) Additional monomers used to synthesize the second screening library.
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Figure 2.
Development of hydrophobic PBAE terpolymers with high DNA transfection potency. a)
Heat map of DNA transfection efficiencies of HeLa cells with the initial terpolymer library
(300 ng DNA/well; 20:1 polymer:DNA w/w). b) Transfection of HeLa cells with lead
polymers from the initial library. c) Heat map of HeLa transfection efficiencies with the
second, focused library (150 ng DNA/well). d) DNA transfection efficiency and e) relative
viability of HeLa cells after treatment with the top PBAE terpolymers at reduced DNA
doses.
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Figure 3.
Effect of alkyl side chains on PBAE transfection efficiency and polyplex stability. a-b)
Stabilities of polyplexes formed from C32-122, D60-C12-122, and D90-C12-122 after self-
assembly in sodium acetate (NaOAc) buffer at pH 5.2 or after dilution in phosphate-buffered
saline (PBS) at pH 7.4. Polyplexes were formed at low DNA concentration (0.03 mg ml−1)
with a polymer:DNA w/w ratio of 20:1. c) HeLa transfection efficiencies and d) polyplex
stabilities of D60-122 polymers synthesized with varying dodecylamine molar feed ratios. e-
f) HeLa transfection efficiencies of C32-122 and DD24-122 polymers (100 ng DNA/well)
synthesized with varying chain lengths and molar feed ratios of alkylamine. At these doses,
C32-122 and DD24-122 synthesized with 0 mol% alkylamine yielded transfection
efficiencies of 0.2% and 4.2%, respectively.
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Figure 4.
Effects of PBAE alkyl side chains (C12) and the presence of PEG-lipid conjugate on
nanoparticle formulation stability at high DNA concentration (0.4 mg ml−1). a) Particle sizes
before and after dialysis against PBS. b) Transfection efficiencies of HeLa cells using equal
doses of each formulation (approximately 75 ng and 150 ng of DNA/well).
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